Cargando…

Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways

CONTEXT: Non-alcoholic fatty liver disease (NAFLD), the most common chronic liver disease, can develop into metabolic associated fatty liver disease (MAFLD). Gypenosides (GP), the main phytochemical component of Gynostemma pentaphylla (Thunb.) Makino (Cucurbitaceae), have been applied for treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Shuhua, Wang, Kungen, Zhi, Yihui, Dong, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553138/ https://www.ncbi.nlm.nih.gov/pubmed/36205541 http://dx.doi.org/10.1080/13880209.2022.2126503

Ejemplares similares

Arabinogalactan Alleviates Lipopolysaccharide-Induced Intestinal Epithelial Barrier Damage through Adenosine Monophosphate-Activated Protein Kinase/Silent Information Regulator 1/Nuclear Factor Kappa-B Signaling Pathways in Caco-2 Cells
por: Zheng, Jiachen, et al.
Publicado: (2023)

Structure of Klebsiella pneumoniae adenosine monophosphate nucleosidase
por: Richardson, Brian C., et al.
Publicado: (2022)

Irisin Protects Against Motor Dysfunction of Rats with Spinal Cord Injury via Adenosine 5'-Monophosphate (AMP)-Activated Protein Kinase-Nuclear Factor Kappa-B Pathway
por: Jiang, Xi, et al.
Publicado: (2020)

The stable cyclic adenosine monophosphate analogue, dibutyryl cyclo-adenosine monophosphate (bucladesine), is active in a model of acute skin inflammation
por: Rundfeldt, Chris, et al.
Publicado: (2012)

CYCLIC ADENOSINE MONOPHOSPHATE IN PHAGOCYTIZING GRANULOCYTES AND ALVEOLAR MACROPHAGES
por: Seyberth, H. W., et al.
Publicado: (1973)

Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016)

Gypenoside-14 Reduces Depression via Downregulation of the Nuclear Factor Kappa B (NF-kB) Signaling Pathway on the Lipopolysaccharide (LPS)-Induced Depression Model
por: Jiang, Yaqun, et al.
Publicado: (2023)

Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells
por: Yamaguchi, Hiroshi, et al.
Publicado: (2014)

Downregulation of cyclic adenosine monophosphate levels in leukocytes of hibernating captive black bears is similar to reported cyclic adenosine monophosphate findings in major depressive disorder
por: Tsiouris, John A., et al.
Publicado: (2023)

Gypenoside Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of Mitogen-Activated Protein Kinase Mediated Nuclear Factor Kappa B Pathway In Vitro and In Vivo
por: Yu, Haijie, et al.
Publicado: (2016)

Cyclic Guanosine Monophosphate–Adenosine Monophosphate Synthase (cGAS), a Multifaceted Platform of Intracellular DNA Sensing
por: Verrier, Eloi R., et al.
Publicado: (2021)

EFFECT OF ADENOSINE 3'-5'-CYCLIC MONOPHOSPHATE ON CELL PROLIFERATION
por: Froehlich, Jeffrey E., et al.
Publicado: (1972)

Factors associated with hyperresponsiveness to adenosine 5’‐monophosphate in healthy subjects
por: Cox, Claire Alette, et al.
Publicado: (2019)

Roles of adenosine monophosphate-activated protein kinase (AMPK) in the kidney
por: Zhu, Na, et al.
Publicado: (2022)

Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
por: Zhao, Jie, et al.
Publicado: (2021)

Determination of Gypenoside A and Gypenoside XLIX in Rat Plasma by UPLC-MS/MS and Applied to the Pharmacokinetics and Bioavailability
por: He, Yan, et al.
Publicado: (2022)

Molecular characterization of adenosine monophosphate deaminase 1 and its regulatory mechanism for inosine monophosphate formation in triploid crucian carp
por: Zhou, Yonghua, et al.
Publicado: (2022)

Intracerebral microdialysis of adenosine and adenosine monophosphate – a systematic review and meta‐regression analysis of baseline concentrations
por: van der Mierden, Stevie, et al.
Publicado: (2018)

Antibody-induced changes in levels of cyclic adenosine monophosphate in leukaemic lymphocytes.
por: Virji, M., et al.
Publicado: (1979)

Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes
por: Ha, Tae-Sun, et al.
Publicado: (2014)

Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
por: Hajra, A, et al.
Publicado: (2017)

Fear renewal activates cyclic adenosine monophosphate signaling in the dentate gyrus
por: Shi, Yan-Wei, et al.
Publicado: (2019)

Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
por: Dutta, D, et al.
Publicado: (2017)

Visualizing Cyclic Adenosine Monophosphate in Cardiac Microdomains Involved in Ion Homeostasis
por: Dikolayev, Vladimir, et al.
Publicado: (2019)

The role of bacterial cyclic di-adenosine monophosphate in the host immune response
por: Cheng, Xingqun, et al.
Publicado: (2022)

Sepsis induces variation of intestinal barrier function in different phase through nuclear factor kappa B signaling
por: Cao, Ying-Ya, et al.
Publicado: (2021)

Inhibition of Adenosine Monophosphate–Activated Protein Kinase–3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Signaling Leads to Hypercholesterolemia and Promotes Hepatic Steatosis and Insulin Resistance
por: Loh, Kim, et al.
Publicado: (2018)

A Novel Adenosine Precursor 2′,3′-Cyclic Adenosine Monophosphate Inhibits Formation of Post-surgical Adhesions
por: Forman, Mervyn B., et al.
Publicado: (2014)

Neutrophil-derived 5′-Adenosine Monophosphate Promotes Endothelial Barrier Function via CD73-mediated Conversion to Adenosine and Endothelial A(2B )Receptor Activation
por: Lennon, Paul F., et al.
Publicado: (1998)

Postreceptor signal transduction by cyclic adenosine monophosphate and the Ca2+-calmodulin complex
por: Means, A. R., et al.
Publicado: (1984)

Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancers.
por: Ramage, A. D., et al.
Publicado: (1994)

Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppression
por: Bopp, Tobias, et al.
Publicado: (2007)

Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes
Publicado: (1979)

The Effect of Norepinephrine and Dibutyryl Cyclic Adenosine Monophosphate on Cation Transport in Duck Erythrocytes
por: Riddick, D. H., et al.
Publicado: (1971)

THE ROLE OF ADENOSINE 3',5'-CYCLIC MONOPHOSPHATE IN THE REGULATION OF MAMMALIAN CELL DIVISION
por: Abell, C. W., et al.
Publicado: (1973)

“cAMP Sponge”: A Buffer for Cyclic Adenosine 3′, 5′-Monophosphate
por: Lefkimmiatis, Konstantinos, et al.
Publicado: (2009)

The Clinical Correlation of Regulatory T Cells and Cyclic Adenosine Monophosphate in Enterovirus 71 Infection
por: Wang, Shih-Min, et al.
Publicado: (2014)

Liquiritigenin enhances cyclic adenosine monophosphate production to mitigate inflammation in dendritic cells
por: Qin, Mingming, et al.
Publicado: (2021)

Adenosine-Monophosphate-Assisted Homogeneous Silica Coating of Silver Nanoparticles in High Yield
por: Fernández-Lodeiro, Carlos, et al.
Publicado: (2023)

Blocking Nuclear Factor-Kappa B Protects against Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice
por: Zeng, Tianshu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_plrscgus4fnta8r3raak20qqom